SCPH Logo

scPharmaceuticals Inc. (SCPH) 

NASDAQ
Market Cap
$160.08M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
741 of 809
Rank in Industry
409 of 445

Largest Insider Buys in Sector

SCPH Stock Price History Chart

SCPH Stock Performance

About scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Insider Activity of scPharmaceuticals Inc.

Over the last 12 months, insiders at scPharmaceuticals Inc. have bought $0 and sold $0 worth of scPharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at scPharmaceuticals Inc. have bought $7.77M and sold $1.56M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 762,380 shares for transaction amount of $4M was made by ORBIMED ADVISORS LLC (director) on 2022‑11‑25.

List of Insider Buy and Sell Transactions, scPharmaceuticals Inc.

2022-11-25PurchaseORBIMED ADVISORS LLCdirector
762,380
1.7007%
$5.25$4M+1.99%
2022-10-10SaleSchwab Andrew J.director
562,466
1.831%
$4.09$2.3M+91.04%
2022-10-06SaleSchwab Andrew J.director
37,534
0.1225%
$5.02$188,421+56.10%
2022-09-06SaleSchwab Andrew J.
6,793
0.022%
$4.75$32,267+43.28%
2022-04-11SaleSchwab Andrew J.
220,096
0.776%
$5.00$1.1M+10.62%
2021-12-03PurchaseTucker John HPresident and CEO
10,000
0.0373%
$3.96$39,553+30.15%
2021-12-03PurchaseKhattar Jack A.director
5,000
0.0184%
$3.91$19,569+30.15%
2021-03-15SaleRA CAPITAL MANAGEMENT, L.P.10 percent owner
110,588
0.3963%
$7.03$777,788-20.33%
2021-03-12SaleRA CAPITAL MANAGEMENT, L.P.10 percent owner
39,469
0.1461%
$7.22$284,816-19.78%
2020-05-26PurchaseSchwab Andrew J.10 percent owner
578,034
2.5395%
$8.65$5M-12.34%
2020-05-21PurchaseORBIMED ADVISORS LLC10 percent owner
1.39M
6.0411%
$8.65$12M-12.99%
2020-02-14PurchaseRA CAPITAL MANAGEMENT, L.P.10 percent owner
271,993
1.2768%
$8.20$2.23M-7.06%
2019-12-13PurchaseTucker John HPresident and CEO
5,000
0.0266%
$5.24$26,189+52.26%
2019-04-11PurchaseRA CAPITAL MANAGEMENT, LLC10 percent owner
389,862
2.1623%
$2.70$1.05M+109.92%
2017-11-21PurchaseORBIMED ADVISORS LLC10 percent owner
833,333
9.7286%
$14.00$11.67M-28.96%
2017-11-21PurchaseLundbeckfond Invest A/S10 percent owner
1.31M
15.2879%
$14.00$18.33M-28.96%
2017-11-21PurchaseAgger Mette Kirstine
1.31M
15.2879%
$14.00$18.33M-28.96%
2017-11-21Purchase5AM Partners IV, LLC10 percent owner
1.31M
7.6439%
$7.00$9.17M-28.96%
2017-11-21PurchaseSUN PHARMACEUTICAL INDUSTRIES LTD10 percent owner
714,286
8.3388%
$14.00$10M-28.96%

Insider Historical Profitability

3.64%
ORBIMED ADVISORS LLCdirector
5328328
14.8585%
$4.4430<0.0001%
Agger Mette Kirstine
3183986
8.8788%
$4.4410<0.0001%
Lundbeckfond Invest A/S10 percent owner
3183986
8.8788%
$4.4410<0.0001%
5AM Partners IV, LLC10 percent owner
3123302
8.7096%
$4.4410<0.0001%
RA CAPITAL MANAGEMENT, L.P.10 percent owner
2727446
7.6057%
$4.4422+51.43%
SUN PHARMACEUTICAL INDUSTRIES LTD10 percent owner
357143
0.9959%
$4.4410<0.0001%
Schwab Andrew J.director
92983
0.2593%
$4.4414<0.0001%
Tucker John HPresident and CEO
46962
0.131%
$4.4420+41.21%
Khattar Jack A.director
5000
0.0139%
$4.4410+30.15%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
OrbiMed$27.91M15.425.56M0%+$00.57
Helm Capital Management LLC$17.7M9.783.52M+0.71%+$125,500.000.52
Aigh Capital Management Llc$17.01M9.43.39M+9.09%+$1.42M10.1
BlackRock$9.04M51.8M-3.32%-$310,381.57<0.0001
Luther King Capital Management$7.29M4.031.45M+4.28%+$299,242.210.03
The Vanguard Group$6.88M3.81.37M<0.01%-$261.04<0.0001
5Am Venture Management Llc$6.03M3.331.2M0%+$00.41
J. Goldman & Company$5.62M3.11.12M-20.36%-$1.44M0.26
Thrivent Financial For Lutherans$5.36M2.961.07M+1.65%+$86,853.390.01
Tejara Capital Ltd$3.5M1.94698,186-7.86%-$299,116.721.19
Citadel Advisors LLC$2.9M1.6576,913+313.57%+$2.2M<0.01
State Street$2.89M1.6575,266+2.67%+$75,018.87<0.0001
Walleye Capital$2.79M1.54556,186-33.7%-$1.42M0.01
Geode Capital Management$2.72M1.5541,843+0.76%+$20,559.12<0.0001
Stonepine Capital Management Llc$2.24M1.24446,776New+$2.24M1.81
Rice Hall James & Associates, LLC$1.41M0.78281,105+247.03%+$1M0.09
Northern Trust$1.33M0.73264,809-1.57%-$21,219.54<0.0001
Renaissance Technologies$1.19M0.65235,958+463.15%+$974,574.84<0.01
Kennedy Capital Management Inc$1.1M0.61219,754-1.46%-$16,294.920.02
Millennium Management LLC$949,202.000.52189,084-47.02%-$842,301.06<0.01
Bridgeway Capital Management$948,780.000.52189,000+31.25%+$225,900.000.02
Morgan Stanley$907,214.000.5180,720-9%-$89,687.28<0.0001
Dimensional Fund Advisors$834,405.000.46166,216-4.24%-$36,932.17<0.0001
Nuveen$454,325.000.2590,5030%+$0<0.0001
Ameriprise Financial$431,031.000.2485,863-2.29%-$10,085.15<0.0001
Raymond James Associates$426,946.000.2485,049-2.3%-$10,040.00<0.0001
BNY Mellon$375,658.000.2174,832-8.21%-$33,624.08<0.0001
Charles Schwab$364,241.000.272,558-6.27%-$24,362.05<0.0001
Squarepoint Ops LLC$312,560.000.1762,263+24.39%+$61,289.13<0.01
Thomasville National Bank$184,736.000.136,800+11.52%+$19,076.000.02
RhumbLine Advisers$182,926.000.136,441+2.12%+$3,794.96<0.0001
Jane Street Capital$177,994.000.135,457+48.47%+$58,106.45<0.0001
UBS$171,854.000.134,234+16.07%+$23,789.69<0.0001
Connor Clark & Lunn Investment Management Ltd$163,311.000.0932,532New+$163,311.00<0.0001
Goldman Sachs$142,312.000.0828,349-37.27%-$84,571.95<0.0001
Bank of America$141,961.000.0828,279-13.19%-$21,560.96<0.0001
Susquehanna International Group$134,978.000.0826,888-58.45%-$189,901.92<0.0001
Mitsubishi UFJ Kokusai Asset Management$103,583.000.0620,634-21.25%-$27,951.45<0.0001
Barclays$102,000.000.0620,304-48.84%-$97,363.18<0.0001
Assenagon Asset Management S.A.$99,506.000.0619,822New+$99,506.00<0.0001
Virtu Financial Llc$90,000.000.0517,895New+$90,000.000.01
MetLife Investment Management$76,826.000.0415,304-0.12%-$95.38<0.0001
Sherbrooke Park Advisers Llc$72,398.000.0414,422New+$72,398.000.01
Deutsche Bank$71,947.000.0414,332+806.51%+$64,010.34<0.0001
CAPTRUST$70,546.000.0414,053New+$70,546.00<0.0001
American International Group$71,445.000.0414,232-0.86%-$617.46<0.0001
Invesco$63,769.000.0412,703-0.56%-$361.44<0.0001
The Manufacturers Life Insurance Company$61,751.000.0312,301+0.77%+$471.88<0.0001
JPMorgan Chase$60,285.000.0312,009-38.73%-$38,101.69<0.0001
IPG INVESTMENT ADVISORS, LLC$60,240.000.0312,0000%+$00.01